Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 5/20 | 0.50 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CDA | P32320 | 1/20 | 0.46 |
| ▸ | PYGM | P11217 | 3/20 | 0.45 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.45 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.45 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.45 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.45 |
| ▸ | TYMP | P19971 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9394257 | 1.00 | SLC5A2 (0.50) | SLC5A2SLC5A1MAPTCDAPYGM | |
| SCHEMBL7640658 | 0.86 | MAPT (0.47) | SLC5A2MAPTCDAPYGMSLC28A1 | |
| SCHEMBL635155 | 0.86 | MAPT (0.47) | SLC5A2MAPTCDAPYGMSLC28A1 | |
| SCHEMBL9060238 | 0.83 | PYGM (0.58) | MAPTCDAPYGMSLC28A1SLC28A2 | |
| SCHEMBL9060208 | 0.83 | PYGM (0.58) | MAPTCDAPYGMSLC28A1SLC28A2 | |
| SCHEMBL9063799 | 0.80 | SLC5A2 (0.45) | SLC5A2MAPTCDAPYGM | |
| SCHEMBL9063307 | 0.79 | PYGM (0.46) | MAPTCDAPYGMSLC28A1SLC28A2 | |
| SCHEMBL9251595 | 0.76 | TYMP (0.48) | SLC5A2SLC5A1MAPTCDAPYGM | |
| SCHEMBL17114013 | 0.76 | TYMP (0.48) | SLC5A2SLC5A1MAPTCDAPYGM | |
| SCHEMBL2577325 | 0.75 | PYGM (0.69) | SLC5A2MAPTPYGMSLC28A1SLC28A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2967078-A1 | THYMIDINE KINASE DIAGNOSTIC ASSAY FOR GENE THERAPY APPLICATIONS | Epeius Biotechnologies Corporation (US) | 2016-01-20 | — | — | EP | claimed |
| CN-105246337-A | Thymidine kinase diagnostic assays for gene therapy applications | EPEIUS BIOTECHNOLOGIES CORP | 2016-01-13 | — | — | CN | claimed |
| WO-2014153205-A1 | THYMIDINE KINASE DIAGNOSTIC ASSAY FOR GENE THERAPY APPLICATIONS | EPEIUS BIOTECHNOLOGIES CORPORATION (US) | 2014-09-25 | — | — | WO | claimed |
| EP-4423288-A2 | COMPOSITIONS AND METHODS FOR THERAPEUTIC OR VACCINE DELIVERY | GenVivo, Inc. (US) | 2024-09-04 | — | — | EP | disclosed |
| WO-2023076180-A2 | COMPOSITIONS AND METHODS FOR THERAPEUTIC OR VACCINE DELIVERY | Genvivo, Inc. (US) | 2023-05-04 | — | — | WO | disclosed |
| EP-2967078-A1 | THYMIDINE KINASE DIAGNOSTIC ASSAY FOR GENE THERAPY APPLICATIONS | Epeius Biotechnologies Corporation (US) | 2016-01-20 | — | — | EP | disclosed |
| CN-105246337-A | Thymidine kinase diagnostic assays for gene therapy applications | EPEIUS BIOTECHNOLOGIES CORP | 2016-01-13 | — | — | CN | disclosed |
| WO-2014153205-A1 | THYMIDINE KINASE DIAGNOSTIC ASSAY FOR GENE THERAPY APPLICATIONS | EPEIUS BIOTECHNOLOGIES CORPORATION (US) | 2014-09-25 | — | — | WO | disclosed |